Drug – bio-affecting and body treating compositions – Designated organic nonactive ingredient containing other... – Aftertreated solid synthetic organic polymer
Patent
1997-12-05
2000-05-02
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic nonactive ingredient containing other...
Aftertreated solid synthetic organic polymer
604 20, A61K 3108, A61N 130
Patent
active
060573740
ABSTRACT:
An electrotransport drug-containing composition is provided. The composition includes a drug to be delivered through a body surface (eg, skin) of a patient, and a permeation enhancer which is solid or semisolid at temperatures typically encountered during storage of pharmaceuticals (eg, temperatures up to at least about 25.degree. C.). The composition of the invention may be applied from a device 10 suitable for electrotransport delivery. A method for increasing electrotransport agent delivery rate and reducing body surface resistance relies on applying the composition of the invention to the body surface, and applying an electric current through the composition and the body surface.
REFERENCES:
patent: 4605670 (1986-08-01), Saito et al.
patent: 4722726 (1988-02-01), Sanderson et al.
patent: 5023085 (1991-06-01), Francoeur et al.
patent: 5087241 (1992-02-01), Mathiesen et al.
patent: 5087242 (1992-02-01), Petelenz et al.
patent: 5128376 (1992-07-01), Saito et al.
patent: 5158537 (1992-10-01), Haak et al.
patent: 5310404 (1994-05-01), Gyory et al.
Wong et al, Pharmaceutical Research, vol. 6, No. 4, 1989, "New Alkyl,N,N-Dialkyl-Substituted Amino Acetates as Transdermal Penetration Enhancers".
Wong et al, International Journal of Pharmaceutics, vol. 52, 1989, pp. 191-202, "Unsaturated Cyclic Urea as New Non-Toxic Biodegradable Transdermal Penetration Enhancers. II. Evaluation Study".
Wong et al, Journal of Pharmaceutical Sciences, vol. 77, No. 11, Nov. 1988, pp. 967-971, "Unsaturated Cyclic Ureas as New Nontoxic Biodegradable Transdermal Penetration Enhancers I: Synthesis".
Pfister et al, Pharmaceutical Technology, Oct. 1990, pp. 54-60, "Permeation Enhancers Compatible with Transdermal Drug Delivery Systems: Part II: System Design Considerations".
Database WPI, Section Ch, Week 9408, Derwent Publications Ltd., London, GB; Class B05, p. P34, AN 94-061979 & JP A 06016538 (Japan Tobacco Inc.) *Abstract* HCP Plus 115:239573 (1991), YU et al.
Rolf, Pharmaceutical Technology, "Chemical and Physical Methods of Enhancing Transdermal Drug Delivery", Sep. 1988, pp. 130-139.
Cullander, Advanced Drug Delivery Reviews, "What are the Pathways of Iontophoretic Current Flow Through Mammalian Skin?", 9, 1992, pp. 119-135.
Barry, Journal of Controlled Release, Mode of Action of Penetration Enhancers in Human Skin, 6, 1987, pp. 85-97.
Terzo et al, Pharmaceutical Research, "Iontophoretic Transport of a Homologous Series of Ionized and Nonionized Model Compounds: Influence of Hydrophobicity and Mechanistic Interpretation", vol. 6, No. 1, 1989, pp. 85-90.
Hiroven et al, Proceed. Inter. Symp. Control. Rel. Bioact. Meter., "Transdermal Premeation of Model Anions and Cations: Effect of Skin Charge, Iontophoresis and Penetration Enhancers", #1303, 19, 1992.
Kontturi et al, Pharmaceutical Research, "Electrochemical Characterization of Human Skin by Impedance of Spectroscopy: The Effect of Penetration Enhancers", vol. 10, No. 3, 1989, pp. 381-385.
Chandrashekar et al, Indian J. Pharm. Sci., "Optimization of Parameters for Transdermal Permeation of Insulin", 56(6), (1194), pp. 205-209.
Cormier Michel
Huntington James A.
ALZA Corporation
Fay Zohreh
Miller D. Byron
Stone Steven F.
LandOfFree
Composition, device, and method for electrotransport agent deliv does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition, device, and method for electrotransport agent deliv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition, device, and method for electrotransport agent deliv will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1594424